FdaApplication
NDA 205525
Identifiers
- fda_app_no: NDA205525
Properties
| Property | Value |
|---|---|
| applicant_name | WELLHOUSE PHARMA LLC |
| application_type | NDA |
| approval_date | 2017-03-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SYNDROS | DRONABINOL | 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;ORAL |
1 product